# Intrathecal Dexmedetomidine Versus Fentanyl With Bupivacaine in Children Undergoing Major Abdominal Cancer Surgery

> **NCT02861716** · PHASE2 · UNKNOWN · sponsor: **South Egypt Cancer Institute** · enrollment: 60 (estimated)

## Conditions studied

- Intrathecal Dexmedetomidine
- Pediatric Cancer Surgery

## Interventions

- **DRUG:** Bupivacaine
- **DRUG:** Fentanyl
- **DRUG:** Dexmedetomidine

## Key facts

- **NCT ID:** NCT02861716
- **Lead sponsor:** South Egypt Cancer Institute
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2016-08
- **Primary completion:** 2019-02
- **Final completion:** 2019-12
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2018-04-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02861716

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02861716, "Intrathecal Dexmedetomidine Versus Fentanyl With Bupivacaine in Children Undergoing Major Abdominal Cancer Surgery". Retrieved via AI Analytics 2026-06-15 from https://api.ai-analytics.org/clinical/NCT02861716. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*